These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6129834)

  • 1. The pharmacokinetics and pharmacodynamics of sulfinalol hydrochloride in dogs after intravenous administration.
    Park GB; Koss RF; DeFelice AF; O'Neil SK; Edelson J
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):4-13. PubMed ID: 6129834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and disposition of sulfinalol in laboratory animals.
    Benziger DP; Fritz A; Edelson J
    Drug Metab Dispos; 1981; 9(6):493-8. PubMed ID: 6120804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of amosulalol, an alpha, beta-adrenoceptor blocker, in rats, dogs and monkeys.
    Kamimura H; Sasaki H; Kawamura S
    Xenobiotica; 1984 Aug; 14(8):613-20. PubMed ID: 6149656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between pharmacokinetics and pharmacodynamics of the beta adrenergic blocking drug sotalol in dogs.
    Ishizaki T; Tawara K
    J Pharmacol Exp Ther; 1979 Nov; 211(2):331-7. PubMed ID: 501565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
    Baum T; Sybertz EJ
    Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
    Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
    J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of metabolites in the relationship between pharmacokinetics and the effect of beta blockers. Studies on tolamolol and bufuralol].
    Tschopp JM; Gorgia A; Balant L; Revillard C; Francis RJ; Fabre FJ
    Schweiz Med Wochenschr; 1978 May; 108(20):756-64. PubMed ID: 26114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of atenolol in clinically normal cats.
    Quiñones M; Dyer DC; Ware WA; Mehvar R
    Am J Vet Res; 1996 Jul; 57(7):1050-3. PubMed ID: 8807020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacologic effects of the S(-) isomer of bupivacaine after intravenous and epidural administration in dogs.
    Franquelo C; Toledo A; Manubens J; Valladares JE; Cristòfol C; Arboix M
    Am J Vet Res; 1999 Jul; 60(7):832-5. PubMed ID: 10407475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of flunixin meglumine in dogs.
    Hardie EM; Hardee GE; Rawlings CA
    Am J Vet Res; 1985 Jan; 46(1):235-7. PubMed ID: 3970431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and antihypertensive effect of oral pelanserin in renal hypertensive dogs.
    Flores-Murrieta FJ; Castañeda-Hernández G; Hong E
    Arzneimittelforschung; 1992 Sep; 42(9):1105-8. PubMed ID: 1445477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.
    Elliott HL; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):573-8. PubMed ID: 6145441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of amosulalol hydrochloride, a new combined alpha- and beta-adrenoceptor blocking agent, in rats, dogs and monkeys.
    Sasaki H; Kamimura H; Kaniwa H; Kawamura S; Takaichi M; Yokoshima T
    Xenobiotica; 1984 Aug; 14(8):621-31. PubMed ID: 6149657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of 4-aminopyridine in anesthetized dogs.
    Rupp SM; Shinohara Y; Fisher DM; Miller RD; Castagnoli N
    J Pharmacol Exp Ther; 1983 May; 225(2):351-4. PubMed ID: 6842398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmental and noncompartmental pharmacokinetic analyses of minocycline hydrochloride in the dog.
    Wilson RC; Kitzman JV; Kemp DT; Goetsch DD
    Am J Vet Res; 1985 Jun; 46(6):1316-8. PubMed ID: 4026008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma nicotine pharmacokinetics in dogs after intravenous administration: determination by radioimmunoassay.
    Monji N; Castro A
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):267-77. PubMed ID: 461952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.